Why CBRE Stock Triumphed on Tuesday Two days before it's set to report third-quarter earnings, the company announced a new acquisition.
Netflix Cut Its Ad Revenue Forecast by $300 Million. Does That Matter More Than Its Earnings Beat? Netflix's ad business has been seen as a valuable growth opportunity. So why is management cutting its ad forecast?
VinFast: 3 Key Takeaways for Long-Term Investors The company is betting three structural changes can offset mounting EV losses before cash flows from real estate investments arrive in 2027.
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? Amgen boasts stronger revenue growth, while Bristol Myers Squibb generates nearly 60% more free cash flow at half the valuation.
Stock Market Today, Oct. 20: IREN Slides on Funding Worries and Rate Fears AI infrastructure sentiment shifted sharply as the vertically integrated data center operator fell 4%, though peers showed steadier demand, today, Oct. 20, 2026.
Synchrony: 3 Key Takeaways for Long-Term Investors AI partnerships and proprietary data tools position Synchrony at the center of how shopping evolves, protecting competitive moats long-term.
Northrop Grumman: 3 Key Takeaways for Long-Term Investors Microelectronics and quantum tech could unlock commercial revenue streams beyond traditional defense contracts.
Steel Dynamics (STLD) Q3 2026 Earnings Call Transcript Record steel shipments and expanded spreads drove 44% operating income growth.
RBB Bancorp (RBB) Q3 2026 Earnings Call Transcript Net income surged 25% as the bank cut wholesale deposits and strengthened capital.
Dutch Bros vs. Celsius: Which Consumer Stock Is a Better Buy in 2026? Celsius trades at half Dutch Bros' valuation despite triple the free cash flow, but Pepsi dependency poses a hidden risk.
Stock Market Today, Oct. 20: SpaceX Stock Gains After Market Close on Q3 Earnings Report Today, Oct. 20, 2026, options traders priced in an 8% post-earnings swing as investors focus on launch cadence and government demand.
AGNC Investment: 3 Key Takeaways for Long-Term Investors Mortgage cash flows have stabilized as extension risk peaked, making the portfolio's income stream far more predictable for income-focused investors.
Atlantic Union: 3 Key Takeaways for Long-Term Investors Asset sensitivity and commercial borrower resilience position the bank to expand margins even as rates stabilize.
AbbVie vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? AbbVie generates $17.8 billion in annual free cash flow but faces patent cliffs, while Vertex boasts a 33% net margin with concentrated cystic fibrosis exposure.
Mercantile Bank: 3 Key Takeaways for Long-Term Investors A regional bank's ability to hold margins steady depends less on Fed policy than on disciplined funding decisions.
F.N.B.: 3 Key Takeaways for Long-Term Investors Data science and disciplined credit management are protecting profitability as the bank expands market share.
Peoples Bancorp: 3 Key Takeaways for Long-Term Investors Margin expansion and near-record commercial lending suggest the bank's acquisition strategy is translating into tangible operating gains.
